AVEO

AVEO Pharmaceuticals, Inc. News Headlines

$0.89
*  
0.07
8.54%
Get AVEO Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading AVEO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha


AVEO Pharmaceuticals (AVEO) Jumps: Stock Rises 7.2% - Tale of the Tape
3/24/2014 8:39:01 AM - Zacks.com


AVEO Regains AV-203 Rights from Biogen - Analyst Blog
3/21/2014 5:10:01 PM - Zacks.com


Healthcare Stocks Undercut Earlier Market Advance; Gilead Sciences Sinks After Congress Questions Drug Price
3/21/2014 2:45:21 PM - MT Newswires


AVEO Q4 Loss Narrower than Expected - Analyst Blog
3/14/2014 8:10:01 AM - Zacks.com


Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog
2/19/2014 9:27:01 AM - Zacks.com


AVEO/Astellas Terminate Agreement - Analyst Blog
2/18/2014 4:30:01 PM - Zacks.com


Tracking Seth Klarman's Baupost Group Holdings - Q4 2013 Update
2/14/2014 3:01:00 AM - Seeking Alpha


AVEO/Astellas Terminate Tivozanib Trial - Analyst Blog
1/31/2014 5:10:01 PM - Zacks.com


AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape
12/31/2013 8:44:01 AM - Zacks.com


Chelsea: FDA Panel Meeting And Trading Strategies
12/30/2013 4:34:00 PM - Seeking Alpha


AVEO Falls on Tivozanib News - Analyst Blog
12/16/2013 6:20:01 PM - Zacks.com


AVEO Q3 Loss Wider than Expected, Shares Down - Analyst Blog
11/12/2013 9:05:12 AM - Zacks.com


Karyopharm Therapeutics IPO Looks Promising
11/6/2013 7:44:00 AM - Seeking Alpha


Wild Card Wonders, Shopping for 52-Week Lows
9/28/2013 8:32:55 PM - GuruFocus


Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low
9/3/2013 10:34:28 AM - GuruFocus


Looking At AVEO With Fresh Eyes
8/29/2013 10:47:00 AM - Seeking Alpha


9 Compelling Reasons To Buy Opexa Therapeutics Right Now
8/15/2013 12:44:00 PM - Seeking Alpha


Merrimack: Undervalued Because Of Misunderstanding And Miscommunication?
8/15/2013 2:30:00 AM - Seeking Alpha


Merrimack: Undervalued Because Of Misunderstanding And Miscommunication?
8/15/2013 12:07:40 AM - SeekingAlpha


Tracking Seth Klarman's Baupost Group Holdings - Q2 2013 Update
8/14/2013 12:57:00 PM - Seeking Alpha


FDA's Rejection Of Aveo's Tivozanib Defies Logic
8/14/2013 11:15:00 AM - Seeking Alpha


AVEO Pharma Cuts Q2 Loss - Analyst Blog
8/14/2013 8:55:52 AM - Zacks.com


Sector Update: Healthcare Shares Higher; Stereotaxis Drops 43% On Q2 Results
8/8/2013 7:29:18 AM - MT Newswires


Sector Update: Healthcare
8/8/2013 7:26:46 AM - MT Newswires